Activity of brigatinib in crizotinib and ceritinib-resistant ROS1- rearranged non-small-cell lung cancer

Aparna Hegde; David S. Hong; Amini Behrang; Siraj M. Ali; Luke Juckett; Funda Meric-Bernstam; Vivek Subbiah

doi:10.1200/PO.18.00267

Activity of brigatinib in crizotinib and ceritinib-resistant ROS1- rearranged non-small-cell lung cancer

Aparna Hegde, David S. Hong, Amini Behrang, Siraj M. Ali, Luke Juckett, Funda Meric-Bernstam, Vivek Subbiah

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	1-6
Number of pages	6
Journal	JCO Precision Oncology
Volume	3
DOIs	https://doi.org/10.1200/PO.18.00267
State	Published - 2019

ASJC Scopus subject areas

Cancer Research
Oncology

MD Anderson CCSG core facilities

Clinical Trials Office

Access to Document

10.1200/PO.18.00267

Cite this

@article{181e5b300c324e468ea60ac48a082cf7,

title = "Activity of brigatinib in crizotinib and ceritinib-resistant ROS1- rearranged non-small-cell lung cancer",

author = "Aparna Hegde and Hong, {David S.} and Amini Behrang and Ali, {Siraj M.} and Luke Juckett and Funda Meric-Bernstam and Vivek Subbiah",

year = "2019",

doi = "10.1200/PO.18.00267",

language = "English (US)",

volume = "3",

pages = "1--6",

journal = "JCO Precision Oncology",

issn = "2473-4284",

publisher = "American Society of Clinical Oncology",

}

TY - JOUR

T1 - Activity of brigatinib in crizotinib and ceritinib-resistant ROS1- rearranged non-small-cell lung cancer

AU - Hegde, Aparna

AU - Hong, David S.

AU - Behrang, Amini

AU - Ali, Siraj M.

AU - Juckett, Luke

AU - Meric-Bernstam, Funda

AU - Subbiah, Vivek

PY - 2019

Y1 - 2019

UR - http://www.scopus.com/inward/record.url?scp=85073408588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073408588&partnerID=8YFLogxK

U2 - 10.1200/PO.18.00267

DO - 10.1200/PO.18.00267

M3 - Article

C2 - 32775947

AN - SCOPUS:85073408588

SN - 2473-4284

VL - 3

SP - 1

EP - 6

JO - JCO Precision Oncology

JF - JCO Precision Oncology

ER -

Activity of brigatinib in crizotinib and ceritinib-resistant ROS1- rearranged non-small-cell lung cancer

ASJC Scopus subject areas

MD Anderson CCSG core facilities

Access to Document

Other files and links

Cite this